Coverage
-
May 12, 2026
A cannabis company CEO testified Tuesday as the first witness in Citron Research founder Andrew Left's criminal securities fraud trial, telling a California federal jury that Left published an inaccurate short sale report on his company that quickly tanked its stock even though it appears he lacked the "conviction" of his attack.
3 other articles on this case.
View all »